Edgewise Therapeutics, Inc.EWTXNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+31.4%
5Y CAGR+78.5%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+31.4%/yr
Annual compound
5Y CAGR
+78.5%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
18.1x
Strong expansion
Streak
6 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $40.02M | +25.6% |
| 2024 | $31.87M | +35.9% |
| 2023 | $23.45M | +33.1% |
| 2022 | $17.63M | +59.9% |
| 2021 | $11.03M | +399.1% |
| 2020 | $2.21M | +69.9% |
| 2019 | $1.30M | - |